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ABSTRACT 
Sarcopenia is an age-related condition associated with rapid loss of skeletal muscle (SKM) tissue that 
affects mobility and quality of life of geriatric individuals. Mechanistic Target of Rapamycin (mTOR) and 
Protein Kinase B (AKT) have significant roles in SKM hypertrophy with responses to DNA damage and 
repair within SKM. However, mTOR and AKT expression is significantly decreased with age. Upstream of 
AKT, Bone Morphogenetic Protein (BMP7) is a member of the TGF-β signaling family that has been 
reported as a positive regulator of muscle hypertrophy through the Bmp–Smad1/5/8 signaling axis. 
PURPOSE: To use an in vitro model of aging muscle cells to investigate the role of BMP7 expression on 
protein synthesis. METHODS: Human SKM myoblasts were cultured and grown beyond mature 
myotube formation (typically day 6) to emulate aged SKM tissue (extracted on day 18). Groups included 
control cells (D6) and aged SKM myotubes (D18). Total RNA was extracted at the respective time points 
(days 6 & 18) and gene expression for BMP7, mTOR, and AKT was determined by qPCR. RESULTS: 
BMP7 expression was 7.73 fold greater for D18 compared to D6 (p < 0.05). No differences were reported 
for AKT or mTOR. Data are expressed as fold changes. CONCLUSION: BMP7 expression, thought to be a 
positive regulator of muscle hypertrophy, was increased in the aging muscle cells of our model, despite 
our hypothesis that it would be decreased. However, BMP7’s downstream targets related to increased 
protein synthesis, mTOR and AKT, did not similarly increase from D6 to D18, which is constant with the 
phenomena of sarcopenia. This leads us to speculate that there may be additional mechanisms related to 
BMP7 activation and, despite increased signaling, may block protein synthesis at the level of AKT.  
 
 
